ProfileGDS4459 / ENSG00000177663
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 64% 63% 73% 71% 70% 66% 71% 69% 67% 71% 65% 69% 72% 67% 68% 68% 64% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.9564
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.8563
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.673
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.2771
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.3370
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.0566
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.5171
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.3169
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.2167
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.4471
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.9465
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.3369
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.4672
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.0267
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.2768
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.0868
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.8964